Human Recombinant ACE2 Reduces the Progression of Diabetic Nephropathy

OBJECTIVE: Diabetic nephropathy is one of the most common causes of end-stage renal failure. Inhibition of ACE2 function accelerates diabetic kidney injury, whereas renal ACE2 is downregulated in diabetic nephropathy. We examined the ability of human recombinant ACE2 (hrACE2) to slow the progression...

Descripción completa

Detalles Bibliográficos
Autores principales: Oudit, Gavin Y., Liu, George C., Zhong, JiuChang, Basu, Ratnadeep, Chow, Fung L., Zhou, Joyce, Loibner, Hans, Janzek, Evelyne, Schuster, Manfred, Penninger, Josef M., Herzenberg, Andrew M., Kassiri, Zamaneh, Scholey, James W.
Formato: Texto
Lenguaje:English
Publicado: American Diabetes Association 2010
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2809962/
https://www.ncbi.nlm.nih.gov/pubmed/19934006
http://dx.doi.org/10.2337/db09-1218

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2809962/
https://www.ncbi.nlm.nih.gov/pubmed/19934006
http://dx.doi.org/10.2337/db09-1218

Ejemplares similares